Pls find enclosed herewith Earning Call Transcript

Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai 400 093, India W www.ajantapharma.com 3rd August 2026 BSE LIMITED National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. Dalal Street, C/1, G Block, Bandra Kurla Complex, Mumbai – 400001 Bandra (East), Mumbai – 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ Sub: Written transcript of Earnings call conducted on 30th July 2026 Dear Sir / Madam, Further to our communication dated 30th July 2026 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 30th July 2026 at 4.15 p.m. has been uploaded on the Company’s website and can be accessed through the link https://www.ajantapharma.com/assets/frontend/images/investors/files/quarterly_results/1785751 785_Earnings-Call-Transcript-Q1-(Apr-Jun)-2026-27.pdf This is for your information and records please. Yours faithfully, GAURANG SHAH Sr. VP – Legal & Company Secretary Corporate Identity Number - L24230MH1979PLC022059